This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
As medical device and diagnostic manufacturers continue to develop life enhancing products for patients across the globe, medical product labels hold an increasingly important position in providing critical information to healthcare professionals and patients, focusing on the safe handling and use of the device.
Labeling executives strive to continuously optimize operations, to ensure a streamlined approach to label data collection, as well as regulatory reviews, and face numerous challenges in achieving each step compliantly. Furthermore, with the FDA UDI rule in place for over two years and ongoing implementation within medical technology organizations, lessons can be learned by examining peers’ experiences and provide insight into solutions to maximize the corporate device identification strategy. To provide participants with the best learning experiences possible, the program will discuss and review:
Optimizing International Labeling Operations and Compliance
Clarification of the Recent FDA Requirements
Analyzing Benefits in Utilizing Data Management Systems
Recognizing Workflow and Execution Optimization Strategies
Tom Fischer of PRISYM ID will chair and moderate an interactive break-out session at each event entitled ‘Sharing Knowledge and Experience in Label-Specific Challenges’. During this interactive session, Mr. Fischer will explore how organizations can expedite label change management and documentation. This peer-to-peer learning environment will enable delegates to understand how other companies have overcome similar hurdles through sharing of perspectives and real-life experience.
For more information about PRISYM ID and to arrange a meeting during the conference, please contact [email protected] or call +44 (0)118 936 4400
